RocketDNA Balance Sheet Health
Financial Health criteria checks 5/6
RocketDNA has a total shareholder equity of A$3.8M and total debt of A$241.2K, which brings its debt-to-equity ratio to 6.3%. Its total assets and total liabilities are A$6.1M and A$2.3M respectively.
Key information
6.3%
Debt to equity ratio
AU$241.15k
Debt
| Interest coverage ratio | n/a |
| Cash | AU$1.49m |
| Equity | AU$3.84m |
| Total liabilities | AU$2.28m |
| Total assets | AU$6.12m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: RKT's short term assets (A$3.2M) exceed its short term liabilities (A$1.5M).
Long Term Liabilities: RKT's short term assets (A$3.2M) exceed its long term liabilities (A$775.9K).
Debt to Equity History and Analysis
Debt Level: RKT has more cash than its total debt.
Reducing Debt: Insufficient data to determine if RKT's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: RKT has sufficient cash runway for 8 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: RKT is forecast to have sufficient cash runway for 9 months based on free cash flow estimates, but has since raised additional capital.